Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention

Clinical trial NCT06750731 · RECRUITING

Trial details

NCT number: NCT06750731
Sponsor: Mercy Medical Center
Status: RECRUITING
Study type: OBSERVATIONAL

Inflammatory Bowel Disease (IBD)Crohn's Disease Ulcerative Colitis

Start date: 2025-05-05
Primary completion: 2026-09-30
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.